SwePub
Sök i LIBRIS databas

  Utökad sökning

((WFRF:(Jahnson Staffan)) srt2:(2015-2019)) srt2:(2019)
 

Sökning: ((WFRF:(Jahnson Staffan)) srt2:(2015-2019)) srt2:(2019) > Management and outc...

Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)

Jahnson, Staffan (författare)
Linköpings universitet,Linköping University,Linkoping Univ, Dept Clin & Expt Med, Div Urol, Linkoping, Sweden,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland
Gårdmark, Truls (författare)
Karolinska Institutet,Karolinska Institute,Danderyd Hospital,Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden
Hosseini, Abolfazl (författare)
Karolinska University Hospital,Karolinska Univ Hosp, Dept Urol, Stockholm, Sweden
visa fler...
Jerlström, Tomas (författare)
Örebro University Hospital,Orebro Univ Hosp, Dept Urol, Orebro, Sweden
Liedberg, Fredrik (författare)
Lund University,Lunds universitet,Urologi - blåscancer, Malmö,Forskargrupper vid Lunds universitet,Urology - urothelial cancer, Malmö,Lund University Research Groups,Skåne University Hospital,Skane Univ Hosp, Dept Urol, Malmo, Sweden;Lund Univ, Inst Translat Med, Malmo, Sweden
Malmström, Per-Uno (författare)
Uppsala universitet,Uppsala University,Urologkirurgi,Uppsala Univ, Sweden
Rosell, Johan (författare)
Linköpings universitet,Linköping University,Linkoping Univ, Reg Canc Ctr Southeast Sweden, Linkoping, Sweden;Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden,Avdelningen för kliniska vetenskaper,Medicinska fakulteten,Region Östergötland, Regionalt cancercentrum
Sherif, Amir (författare)
Umeå universitet,Urologi och andrologi,Umea Univ Hosp, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden,Norrland University Hospital
Ströck, Viveka (författare)
Sahlgrenska University Hospital,Sahlgrens Univ Hosp, Dept Urol, Gothenburg, Sweden
Häggström, Christel (författare)
Uppsala universitet,Umeå universitet,Uppsala University,Umeå University,Enheten för biobanksforskning,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden,Endokrinkirurgi,Umea Univ, Dept Biobank Res, Umea, Sweden,Uppsala Univ, Sweden; Umea Univ, Sweden
Holmberg, Lars (författare)
Uppsala universitet,Uppsala University,King's College London,Endokrinkirurgi,Kings Coll London, Sch Med, London, England,Uppsala Univ, Sweden; Kings Coll London, England
Aljabery, Firas (författare)
Linköpings universitet,Linköping University,Linkoping Univ, Dept Clin & Expt Med, Div Urol, Linkoping, Sweden,Institutionen för klinisk och experimentell medicin,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland
visa färre...
 (creator_code:org_t)
2019-05-30
2019
Engelska.
Ingår i: Scandinavian Journal of Urology. - : Medical Journals Sweden AB. - 2168-1805 .- 2168-1813. ; 53:4, s. 200-205
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Purpose: To investigate the management of TaG3 tumours of the urinary bladder using nationwide population-based data in relation to the prevailing guidelines, patients’ characteristics, and outcome. Materials and methods: The Bladder Cancer Data Base Sweden (BladderBaSe), including data from the Swedish National Register for Urinary Bladder Cancer (SNRUBC), was used to study all patients with TaG3 bladder cancer diagnosed from 2008 to 2014. Patients were divided into the following management groups: (1) transurethral resection (TUR) only, (2) TUR and intravesical instillation therapy (IVIT), (3) TUR and second-look resection (SLR), and (4) TUR with both SLR and IVIT. Patient and tumour characteristics and outcome were studied. Results: There were 831 patients (83% males) with a median age of 74 years. SLR was performed more often on younger patients, on men, and less often in the Western and Uppsala/Örebro Healthcare regions. IVIT was performed more often with younger patients, with men, in the Western Healthcare region, and less often in the Uppsala/Örebro Healthcare region. Death from bladder cancer occurred in 6% of cases within a median of 29 months (0–84 months) and was lower in the TUR/IVIT and TUR/SLR/IVIT groups compared to the other two groups. Conclusion: In the present study, there was, according to the prevailing treatment guidelines, an under-treatment with SLR for older patients, women, and in some healthcare regions and, similarly, there was an under-treatment with IVIT for older patients. Cancer-specific survival and relative survival were lower in the TUR only group compared to the TUR/IVIT and TUR/SLR/IVIT groups.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Bladder cancer
intravesical instillation treatment
population-based
second-look resection
TaG3
Bladder cancer

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy